论文部分内容阅读
目的分析曲美他嗪联合美托洛尔治疗冠心病心力衰竭临床效果。方法研究我院在2014年4月~2015年4月接诊的80例冠心病合并心力衰竭患者，分为对照组和观察组各40例，其中对照组采用常规治疗，观察组采用曲美他嗪合并美托洛尔，而后分析两组患者在治疗疗效和相关身体指标上的变换情况。结果在治疗有效率上，观察组为92.5%，对照组为77.5%，<0.05；在血压、心率、LVEF、LVEDD、LVESD的指标上，观察组均优于对照组，<0.05。结论曲美他嗪联合美托洛尔治疗冠心病心力衰竭可以有效提升治疗疗效，快速的改善身体相关指标。“,”Objective To analyze trimetazidine with metoprolol in the treatment of coronary heart clinical results.Methods In our hospital from April 2014 to April 2015,80 cases of coronary heart disease during the admissions with heart failure were randomly divided into control group and observation group,40 cases in which the control group with conventional treatment,observation group song TMZ merger metoprolol,and then analyzed in two groups of patients on therapy and related physical indicators of change situations.Results The ef ective rate in observation group was 92.5%in the control group was 77.5%, <0.05;on blood pressure,heart rate,LVEF,LVEDD,LVESD indicators,the observation group than the control group, <0.05.Conclusion Trimetazidine with metoprolol in the treatment of coronary heart can enhance treatment ef icacy,rapid improvements in health-related indicators.